Is PACS Group, Inc. overvalued?

PACS Group, Inc. (PACS) looks overvalued — trading about 20% above its fair value.

Overvalued

Price

$46.03

Fair value

$36.74

Current P/E

39.1

Normal P/E

31.2

Market cap

$7.29B

Dividend yield

0.0%

Return on equity

27.2%

Sector

Healthcare

Fair value compares PACS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks